Clinical Study

Ucci-Pdx-1601-Tumor Specimen Collection Protocol For Patient Derived Xenograft (Pdx) Modeling

Posted Date: Jul 1, 2019

  • Investigator: Trisha Wise-Draper
  • Specialties: Breast Cancer, Cancer, Esophageal Diseases, Gynecologic Oncology, Lung Cancer, Lymphoma, Oncology, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer
  • Type of Study: Observational/Survey

The goal of this study is to develop a mechanism to collect de-identified but clinically annotated human tissue and cells for the development of PDX models in immunodeficient and immunocompetent humanized mice

Criteria:

To Be Eligible: Must Have Known Diagnoses Of Malignancy, Able To Withstand Blood Withdrawal

Keywords:

Pdx Models, Tissue

For More Information:

Ucci Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.